41 research outputs found
Role of tryptophan residues of Erv1: Trp95 and Trp183 are important for its folding and oxidase function
Erv1 is an FAD-dependent sulphydryl oxidase of the ERV/ALR sub-family, and an essential component of the mitochondrial import and assembly pathway. Erv1 contains six tryptophan residues, which are all located in the highly conserved C-terminal FAD-binding domain. Though important structural roles were predicted for the invariable Trp95, no experimental study has been reported. In this study, we investigated the structural and functional roles of individual Trp residues of Erv1. Six single Trp-to-Phe yeast mutant strains were generated and their effects on cell viability were tested at various temperatures. Then, the mutants were purified from E. coli. Their effects on folding, FAD-binding, and Erv1 activity were characterised. Our results showed that Erv1W95F has the strongest effect on the stability and function of Erv1, and followed by Erv1W183F. Erv1W95F results in a decrease of the Tm of Erv1 by 23°C, a significant loss of the oxidase activity, and thus causing cell growth defects at both 30°C and 37°C. Erv1W183F induces changes in the oligomerisation state of Erv1, along with a pronounced effect on the stability of Erv1 and its function at 37°C, whilst the other mutants had no clear effect on the function of Erv1 including the highly conserved Trp157 mutant. Finally, computational analysis indicates that Trp95 plays a key role in stabilising the isoalloxazine ring to interact with Cys133. Taken together, this study provided important insights into the molecular mechanism of how sulfhydryl oxidases use FAD in catalyzing disulfide bond formation
Spike-Timing Precision and Neuronal Synchrony Are Enhanced by an Interaction between Synaptic Inhibition and Membrane Oscillations in the Amygdala
The basolateral complex of the amygdala (BLA) is a critical component of the neural circuit regulating fear learning. During fear learning and recall, the amygdala and other brain regions, including the hippocampus and prefrontal cortex, exhibit phase-locked oscillations in the high delta/low theta frequency band (∼2–6 Hz) that have been shown to contribute to the learning process. Network oscillations are commonly generated by inhibitory synaptic input that coordinates action potentials in groups of neurons. In the rat BLA, principal neurons spontaneously receive synchronized, inhibitory input in the form of compound, rhythmic, inhibitory postsynaptic potentials (IPSPs), likely originating from burst-firing parvalbumin interneurons. Here we investigated the role of compound IPSPs in the rat and rhesus macaque BLA in regulating action potential synchrony and spike-timing precision. Furthermore, because principal neurons exhibit intrinsic oscillatory properties and resonance between 4 and 5 Hz, in the same frequency band observed during fear, we investigated whether compound IPSPs and intrinsic oscillations interact to promote rhythmic activity in the BLA at this frequency. Using whole-cell patch clamp in brain slices, we demonstrate that compound IPSPs, which occur spontaneously and are synchronized across principal neurons in both the rat and primate BLA, significantly improve spike-timing precision in BLA principal neurons for a window of ∼300 ms following each IPSP. We also show that compound IPSPs coordinate the firing of pairs of BLA principal neurons, and significantly improve spike synchrony for a window of ∼130 ms. Compound IPSPs enhance a 5 Hz calcium-dependent membrane potential oscillation (MPO) in these neurons, likely contributing to the improvement in spike-timing precision and synchronization of spiking. Activation of the cAMP-PKA signaling cascade enhanced the MPO, and inhibition of this cascade blocked the MPO. We discuss these results in the context of spike-timing dependent plasticity and modulation by neurotransmitters important for fear learning, such as dopamine
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
BACKGROUND:
Patients with atherosclerotic vascular disease remain at high risk for cardiovascular events despite effective statin-based treatment of low-density lipoprotein (LDL) cholesterol levels. The inhibition of cholesteryl ester transfer protein (CETP) by anacetrapib reduces LDL cholesterol levels and increases high-density lipoprotein (HDL) cholesterol levels. However, trials of other CETP inhibitors have shown neutral or adverse effects on cardiovascular outcomes.
METHODS:
We conducted a randomized, double-blind, placebo-controlled trial involving 30,449 adults with atherosclerotic vascular disease who were receiving intensive atorvastatin therapy and who had a mean LDL cholesterol level of 61 mg per deciliter (1.58 mmol per liter), a mean non-HDL cholesterol level of 92 mg per deciliter (2.38 mmol per liter), and a mean HDL cholesterol level of 40 mg per deciliter (1.03 mmol per liter). The patients were assigned to receive either 100 mg of anacetrapib once daily (15,225 patients) or matching placebo (15,224 patients). The primary outcome was the first major coronary event, a composite of coronary death, myocardial infarction, or coronary revascularization.
RESULTS:
During the median follow-up period of 4.1 years, the primary outcome occurred in significantly fewer patients in the anacetrapib group than in the placebo group (1640 of 15,225 patients [10.8%] vs. 1803 of 15,224 patients [11.8%]; rate ratio, 0.91; 95% confidence interval, 0.85 to 0.97; P=0.004). The relative difference in risk was similar across multiple prespecified subgroups. At the trial midpoint, the mean level of HDL cholesterol was higher by 43 mg per deciliter (1.12 mmol per liter) in the anacetrapib group than in the placebo group (a relative difference of 104%), and the mean level of non-HDL cholesterol was lower by 17 mg per deciliter (0.44 mmol per liter), a relative difference of -18%. There were no significant between-group differences in the risk of death, cancer, or other serious adverse events.
CONCLUSIONS:
Among patients with atherosclerotic vascular disease who were receiving intensive statin therapy, the use of anacetrapib resulted in a lower incidence of major coronary events than the use of placebo. (Funded by Merck and others; Current Controlled Trials number, ISRCTN48678192 ; ClinicalTrials.gov number, NCT01252953 ; and EudraCT number, 2010-023467-18 .)
Human Augmenter of Liver Regeneration: Probing the Catalytic Mechanism of a Flavin-Dependent Sulfhydryl Oxidase
Augmenter of liver regeneration is
a member of the ERV family of
small flavin-dependent sulfhydryl oxidases that contain a redox-active
CxxC disulfide bond in redox communication with the isoalloxazine
ring of bound FAD. These enzymes catalyze the oxidation of thiol substrates
with the reduction of molecular oxygen to hydrogen peroxide. This
work studies the catalytic mechanism of the short, cytokine form of
augmenter of liver regeneration (sfALR) using model thiol substrates
of the enzyme. The redox potential of the proximal disulfide in sfALR
was found to be approximately 57 mV more reducing than the flavin
chromophore, in agreement with titration experiments. Rapid reaction
studies show that dithiothreitol (DTT) generates a transient mixed
disulfide intermediate with sfALR signaled by a weak charge-transfer
interaction between the thiolate of C145 and the oxidized flavin.
The subsequent transfer of reducing equivalents to the flavin ring
is relatively slow, with a limiting apparent rate constant of 12.4
s<sup>–1</sup>. However, reoxidation of the reduced flavin
by molecular oxygen is even slower (2.3 s<sup>–1</sup> at air
saturation) and thus largely limits turnover at 5 mM DTT. The nature
of the charge-transfer complexes observed with DTT was explored using
a range of simple monothiols to mimic the initial nucleophilic attack
on the proximal disulfide. While β-mercaptoethanol is a very
poor substrate of sfALR (∼0.3 min<sup>–1</sup> at 100
mM thiol), it rapidly generates a mixed disulfide intermediate allowing
the thiolate of C145 to form a strong charge-transfer complex with
the flavin. Unlike the other monothiols tested, glutathione is unable
to form charge-transfer complexes and is an undetectable substrate
of the oxidase. These data are rationalized on the basis of the stringent
steric requirements for thiol-disulfide exchange reactions. The inability
of the relatively bulky glutathione to attain the in-line geometry
required for efficient disulfide exchange in sfALR may be physiologically
important in preventing the oxidase from catalyzing the potentially
harmful oxidation of intracellular glutathione
Credibility investigation of newsworthy tweets using a visualising Petri net model
Investigating information credibility is an important problem in online social networks such as Twitter. Since misleading information can get easily propagated in Twitter, ranking tweets according to their credibility can help to detect rumors and identify misinformation. In this paper, we propose a Petri net model to visualise tweet credibility in Twitter. We consider the uniform resource locator (URL) as an effective feature in evaluating tweet credibility since it is used to identify the source of tweets, especially for newsworthy tweets. We perform an experimental evaluation on about 1000 tweets, and show that the proposed model is effective for assigning tweets to two classes: credible and incredible tweets, which each class being further divided into two sub-classes (“credible” and “seem credible” and “doubtful” and “incredible” tweets, respectively) based on appropriate features
The Oxidation of Thiols by Flavoprotein Oxidases: a Biocatalytic Route to Reactive Thiocarbonyls.
Flavoprotein oxidases are a diverse class of biocatalysts, most of which catalyze the oxidation of C[BOND]O, C[BOND]N, or C[BOND]C bonds. Flavoprotein oxidases that are known to catalyze the oxidation of C[BOND]S bonds are rare, being limited to enzymes that catalyze the oxidative cleavage of thioethers. Herein, we report that various flavoprotein oxidases, previously thought to solely act on alcohols, also catalyze the oxidation of thiols to thiocarbonyls. These results highlight the versatility of enzymatic catalysis and provide a potential biocatalytic route to reactive thiocarbonyl compounds, which have a variety of applications in synthetic organic chemistry